Webinar: Screening of Leukemic Neoantigen Specific T-cells with the Intellicyt iQue Screener PLUS

Although cellular therapies are experiencing a great deal of clinical success in recent years, there is still a need for technologies that increase screening capabilities and throughput to gain greater biological insights than what is possible with traditional flow cytometry.

Join Alison Tarke, Research Scientist at Persimmune as she describes the identification of AML neoantigen specific T cells using the iQue Screener PLUS to assess CTL activity by target cell death and cytokine release. Additionally, she describes how they also utilized the iQue Screener PLUS to define leukocyte populations by expression level of CD45 and to measure T cell proliferation in response to neoantigens.

Complete the form below to watch this webinar and learn more.